Wuxi Bio (02269.HK) announced that the board of directors will convene a meeting in Hong Kong on August 21, 2024 (Wednesday) to consider and approve the interim performance of the group for the six months ending June 30, 2024 (including).
药明生物(02269.HK)8月21日举行董事会会议考虑及通过中期业绩
Wuxi Bio (02269.HK) held a board of directors meeting on August 21 to consider and approve the interim performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.